BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19028558)

  • 1. Studies on coumestrol/beta-cyclodextrin association: Inclusion complex characterization.
    Franco C; Schwingel L; Lula I; Sinisterra RD; Koester LS; Bassani VL
    Int J Pharm; 2009 Mar; 369(1-2):5-11. PubMed ID: 19028558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daidzein/cyclodextrin/hydrophilic polymer ternary systems.
    Borghetti GS; Pinto AP; Lula IS; Sinisterra RD; Teixeira HF; Bassani VL
    Drug Dev Ind Pharm; 2011 Aug; 37(8):886-93. PubMed ID: 21247375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
    Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physical and chemical characterization of allantoin-beta-cyclodextrin inclusion complex].
    Gafiţanu C; Popescu C; Singurel G; Macocinschi D
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):173-6. PubMed ID: 15688779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
    Garnero C; Longhi M
    J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of inclusion complex of beta-cyclodextrin and nitrobenzene.
    Chen M; Diao G; Zhang E
    Chemosphere; 2006 Apr; 63(3):522-9. PubMed ID: 16324733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
    Yang B; Lin J; Chen Y; Liu Y
    Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
    Yang ZX; Chen Y; Liu Y
    Carbohydr Res; 2008 Sep; 343(14):2439-42. PubMed ID: 18653172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.
    Ventura CA; Giannone I; Paolino D; Pistarà V; Corsaro A; Puglisi G
    Eur J Med Chem; 2005 Jul; 40(7):624-31. PubMed ID: 15935897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
    de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
    Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-beta-cyclodextrin.
    Zhang M; Li J; Zhang L; Chao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1891-5. PubMed ID: 18722807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isothermal titration calorimetry and 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin.
    Sun DZ; Li L; Qiu XM; Liu F; Yin BL
    Int J Pharm; 2006 Jun; 316(1-2):7-13. PubMed ID: 16554127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.
    Asbahr AC; Franco L; Barison A; Silva CW; Ferraz HG; Rodrigues LN
    Bioorg Med Chem; 2009 Apr; 17(7):2718-23. PubMed ID: 19282187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
    de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
    J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of inclusion complexes of natural and modified cyclodextrin with (+)catechin by NMR and molecular modeling.
    Jullian C; Miranda S; Zapata-Torres G; Mendizábal F; Olea-Azar C
    Bioorg Med Chem; 2007 May; 15(9):3217-24. PubMed ID: 17350847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of olive leaf extract in beta-cyclodextrin.
    Mourtzinos I; Salta F; Yannakopoulou K; Chiou A; Karathanos VT
    J Agric Food Chem; 2007 Oct; 55(20):8088-94. PubMed ID: 17764146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR studies of the inclusion complex between beta-cyclodextrin and paroxetine.
    Bernini A; Spiga O; Ciutti A; Scarselli M; Bottoni G; Mascagni P; Niccolai N
    Eur J Pharm Sci; 2004 Aug; 22(5):445-50. PubMed ID: 15265514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.